Skip to content

Patient Satisfaction and Postoperative Analgesia Between Subarachnoid Block With 2-chloroprocaine Versus General Anesthesia for Knee Arthroscopy

Randomized Controlled Trial Evaluating Patient Satisfaction and Postoperative Analgesia Between Subarachnoid Block With 2-chloroprocaine Versus General Anesthesia for Knee Arthroscopy

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03173326
Enrollment
1
Registered
2017-06-01
Start date
2017-06-16
Completion date
2018-04-20
Last updated
2018-08-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Arthroscopy, General Anesthesia, Subarachnoid Block

Brief summary

The study evaluates the efficacy of two different anesthetic techniques in patients undergoing unilateral knee arthroscopy. Participants will be randomized to receive either subarachnoid block with 2-chloroprocaine or general anesthesia plus intravenous fentanyl.

Detailed description

The study evaluates the efficacy of two different anesthetic techniques in patients undergoing unilateral knee arthroscopy. Participants will be randomized to receive either subarachnoid block with 2-chloroprocaine or general anesthesia plus intravenous fentanyl. The study evaluates pain scores, opioid utilization and patient satisfaction.

Interventions

PROCEDUREGeneral anesthesia

General anesthesia will be delivered per standard procedure. General anesthesia will include induction with propofol 1-3mg/kg followed by placement of a laryngeal mask airway with maintenance anesthesia of sevoflurane 0.5-1 minimum alveolar concentration (MAC).

Neuraxial anesthesia will be performed at the L2-3 or L3-4 interspace with a 25-gauge Whitacre needle in the sitting position. After free flow of cerebrospinal fluid (CSF), 40-45mg of 2-chloroprocaine will be injected based on patient's height and discretion of attending anesthesiologist, needle withdrawn and the patient placed supine.

Sponsors

Vanderbilt University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
30 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Patients with ASA physical status classification of I, II, or III * Patients without a current diagnosis of chronic pain or chronic opioid use for \> 1-month prior to knee arthroscopy * Patients who are scheduled to undergo unilateral knee arthroscopy * Patients do not have a contraindication to receiving regional anesthesia

Exclusion criteria

* Preexisting sensory or motor deficit in operative extremity * Patients with a contraindication to general anesthesia * Patient undergoing meniscal or ligamentous repair

Design outcomes

Primary

MeasureTime frameDescription
Pain scoreDischarge from post anesthesia care unit (PACU) (usually one hour)Pain score measured with a patient reported 11 point Numeric Rating Pain Scale with 0 indicating no pain and 10 indicating worst pain imaginable.
Opioid utilizationSurgical completion to PACU discharge (usually one hour)Opioid utilization based on amount of opioid medications administered

Secondary

MeasureTime frameDescription
Patient satisfaction with anesthetic24 hours after PACU dischargePatient satisfaction with anesthetic based on 10-item patient satisfaction survey validated for regional and general anesthesia

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026